Eric L. Dobmeier

2014

In 2014, Eric L. Dobmeier earned a total compensation of $2.4M as Chief Operating Officer at Seattle Genetics, a 2% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$260,480
Option Awards$841,046
Salary$472,262
Stock Awards$793,620
Other$8,280
Total$2,375,688

Dobmeier received $841K in option awards, accounting for 35% of the total pay in 2014.

Dobmeier also received $260.5K in non-equity incentive plan, $472.3K in salary, $793.6K in stock awards and $8.3K in other compensation.

Rankings

In 2014, Eric L. Dobmeier's compensation ranked 3,855th out of 13,032 executives tracked by ExecPay. In other words, Dobmeier earned more than 70.4% of executives.

ClassificationRankingPercentile
All
3,855
out of 13,032
70th
Division
Manufacturing
1,363
out of 4,966
73rd
Major group
Chemicals And Allied Products
440
out of 1,686
74th
Industry group
Drugs
340
out of 1,365
75th
Industry
Biological Products, Except Diagnostic Substances
56
out of 236
76th
Source: SEC filing on April 5, 2017.

Dobmeier's colleagues

We found five more compensation records of executives who worked with Eric L. Dobmeier at Seattle Genetics in 2014.

2014

Clay Siegall

Seattle Genetics

Chief Executive Officer

2014

Jonathan Drachman

Seattle Genetics

Chief Medical Officer

2014

Christopher Boerner

Seattle Genetics

Former EVP, Commercial

2014

Todd Simpson

Seattle Genetics

Chief Financial Officer

2014

Vaughn Himes

Seattle Genetics

Chief Technical Officer

You may also like